Phase Ib / II clinical trial of ruxolitinib in combination with nilotinib in prednisone for the treatment of niolofribrosis: RuNiC study
INDEPENDENT CLINICAL TRIAL
Clinical trial information
- Sponsor: SPANISH GROUP OF PH NEGATIVE CHRONIC MYELOPROLIFERATIVE DISEASES (GEMFIN)
- Phase: II
- Execution start: 29/09/2017
- End of execution: 30/08/2020
- PI: FRANCISCA HERNANDEZ MOHEDO